Literature DB >> 8228963

Pax: gene regulators in the developing nervous system.

G Chalepakis1, A Stoykova, J Wijnholds, P Tremblay, P Gruss.   

Abstract

In recent years, the discovery of Pax genes in mouse has played an invaluable role in furthering our understanding in mouse developmental processes and disorders. To date, eight murine paired box-containing genes have been cloned. Seven of these exhibit a distinct spatiotemporal expression pattern in the developing nervous system implying a role in the regional specification of the developing spinal cord and brain. The Pax genes encode for sequence-specific DNA binding transcription factors that play a key role in embryonic development. Three of these developmental control genes are altered in mutant mice and two are associated with human diseases. Disruption of these Pax genes leads to abnormalities in neural crest derivatives, neuroectoderm, sclerotome or myotome-derived tissues. Disruption of the Pax-3 gene causes the Splotch phenotype in mice and Waardenburg syndrome in humans. Pax-6 mutations result in Small eye mice and the human genetic disorder aniridia. The Pax-1 gene is mutated in undulated mice. Pax proteins can transform cells in culture which then form tumours following injection in nude mice. Consistent with this activity, PAX3 has been recently implicated in the generation of the tumour alveolar rhabdomyosarcoma.

Entities:  

Mesh:

Year:  1993        PMID: 8228963     DOI: 10.1002/neu.480241009

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  24 in total

1.  The PAX6 gene is activated by the basic helix-loop-helix transcription factor NeuroD/BETA2.

Authors:  Eleonora Marsich; Amedeo Vetere; Matteo Di Piazza; Gianluca Tell; Sergio Paoletti
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

2.  Identification and characterization of a neuroretina-specific enhancer element in the quail Pax-6 (Pax-QNR) gene.

Authors:  S Plaza; C Dozier; M C Langlois; S Saule
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

3.  Tumor-specific PAX3-FKHR transcription factor, but not PAX3, activates the platelet-derived growth factor alpha receptor.

Authors:  J A Epstein; B Song; M Lakkis; C Wang
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

4.  A binding site for Pax proteins regulates expression of the gene for the neural cell adhesion molecule in the embryonic spinal cord.

Authors:  B D Holst; Y Wang; F S Jones; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 5.  Role of the extracellular matrix in neural crest cell migration.

Authors:  D J Henderson; A J Copp
Journal:  J Anat       Date:  1997-11       Impact factor: 2.610

6.  Targeted deletion of AP-2alpha leads to disruption in corneal epithelial cell integrity and defects in the corneal stroma.

Authors:  Dhruva J Dwivedi; Giuseppe F Pontoriero; Ruth Ashery-Padan; Shelley Sullivan; Trevor Williams; Judith A West-Mays
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

7.  Molecular characterization of HLH-17, a C. elegans bHLH protein required for normal larval development.

Authors:  Tracee L McMiller; Casonya M Johnson
Journal:  Gene       Date:  2005-08-15       Impact factor: 3.688

Review 8.  Hox genes and their candidate downstream targets in the developing central nervous system.

Authors:  Z N Akin; A J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

Review 9.  Congenital abnormalities of the optic nerve: from gene mutation to clinical expression.

Authors:  Palak B Wall; Elias I Traboulsi
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

10.  A frameshift mutation in the gene for PAX3 in a girl with spina bifida and mild signs of Waardenburg syndrome.

Authors:  F A Hol; B C Hamel; M P Geurds; R A Mullaart; F G Barr; R A Macina; E C Mariman
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.